Jacobs Levy Equity Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-65,008
| Closed | -$137K | – | 1128 |
|
|
2024
Q4 | $137K | Buy |
+65,008
| New | +$137K | ﹤0.01% | 910 |
|
|
2024
Q3 | – | Sell |
-10,015
| Closed | -$28.5K | – | 991 |
|
|
2024
Q2 | $28.5K | Sell |
10,015
-54,561
| -84% | -$156K | ﹤0.01% | 945 |
|
|
2024
Q1 | $274K | Sell |
64,576
-2,933
| -4% | -$12.4K | ﹤0.01% | 867 |
|
|
2023
Q4 | $361K | Sell |
67,509
-15,228
| -18% | -$81.5K | ﹤0.01% | 869 |
|
|
2023
Q3 | $356K | Sell |
82,737
-14,902
| -15% | -$64.1K | ﹤0.01% | 858 |
|
|
2023
Q2 | $536K | Sell |
97,639
-21,630
| -18% | -$119K | ﹤0.01% | 812 |
|
|
2023
Q1 | $501K | Sell |
119,269
-18,425
| -13% | -$77.4K | ﹤0.01% | 803 |
|
|
2022
Q4 | $381K | Sell |
137,694
-125,312
| -48% | -$347K | ﹤0.01% | 831 |
|
|
2022
Q3 | $673K | Buy |
+263,006
| New | +$673K | 0.01% | 785 |
|
|
2021
Q1 | – | Sell |
-71,060
| Closed | -$305K | – | 1060 |
|
|
2020
Q4 | $305K | Buy |
71,060
+5,427
| +8% | +$23.3K | ﹤0.01% | 921 |
|
|
2020
Q3 | $198K | Sell |
65,633
-2,918
| -4% | -$8.8K | ﹤0.01% | 963 |
|
|
2020
Q2 | $213K | Buy |
+68,551
| New | +$213K | ﹤0.01% | 941 |
|
|
2017
Q2 | – | Sell |
-61,473
| Closed | -$160K | – | 965 |
|
|
2017
Q1 | $160K | Buy |
61,473
+7,165
| +13% | +$18.6K | ﹤0.01% | 818 |
|
|
2016
Q4 | $166K | Buy |
+54,308
| New | +$166K | ﹤0.01% | 850 |
|